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Executive summary 
Kazakhstan is in top 18 countries with the highest TB burden in European region [2, 
9]. The tuberculosis burden for Kazakhstan is very high, annual years of healthy life 
lost per 100,000 people from tuberculosis in Kazakhstan has increased by 19.8% since 
1990, an average of 0.9% a year. This research investigated factors associated with 
treatment outcome failure. The following factors has been examined: age, sex, 
residence, socio-economic status, year of admission, length of stay in the hospital, 
drug resistance, medical organization, hospital admission type. It has been found that 
following factors are associated with increased TB treatment outcome failure: being 
male by 17%; drug resistance by 206%; being emergency admitted to the hospital by 
47%. Factors that are associated with decreased treatment outcome failure: being 
treated in Ust-Kamenogorsk TB center by 34%; being employed (as compared to 
being unemployed) by 36%; being student (as compared to being unemployed) by 
65%; one additional day of stay by 1%. However, it should be admitted that obtained 
factors’ association are generalizable for East-Kazakhstan region only due to study 
design limitations.  
Key words: Tuberculosis, treatment outcome, drug resistance, East-
Kazakhstan region. 
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1. INTRODUCTION  
 Effective tuberculosis (TB) control is largely dependent on successful 
treatment and diagnosis. 53 million lives have been saved between 2000 and 2016 
by TB control strategies [1]. Albeit tremendous efforts, TB is the top infectious 
killer worldwide, and each year over 1 million deaths occur from TB [2]. It should 
be admitted that it is important to identify high risk groups and vulnerable 
population for TB [3-6]. Co-morbidities with TB may complicate the treatment 
and influence on poor outcome of the treatment, including treatment failure and 
death. Primarily, there is high association of TB with HIV and diabetes [7]. Early 
detection and appropriate treatment strategy may reduce transmission rate and 
better treatment outcome, including drug resistance [8]. 
Kazakhstan is in top 18 countries with the highest TB burden in European 
region [2, 9]. The tuberculosis burden for Kazakhstan is very high, annual years of 
healthy life lost per 100,000 people from tuberculosis in Kazakhstan has increased 
by 19.8% since 1990, an average of 0.9% a year. TB control in Kazakhstan is 
managed by Ministry of Health National TB Control program for 2014- 2020. The 
main partners of this program are: WHO, CDC, Global Fund to fight AIDS, TB 
and Malaria (GFATM), and the United States Agency for International 
Development (USAID) through Challenge TB, Project HOPE, TB CARE I, 
KNCV [9, 10]. TB treatment and diagnosis are free across the Kazakhstan [11]. 
Despite these advances in TB control efforts, treatment success rate in Kazakhstan 
of tuberculosis vary across the TB case types: new tuberculosis case treatment 
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success rate is 91%; previously treated TB case treatment success rate is 47%; and 
multi-drug resistance tuberculosis case treatment success is 76%. Moreover, it can 
be observed that country’s success rates for treatment of TB are lower than WHO-
recommended ≥85% cure rate.   
From Ministry of Health order #994: “Instruction on the organization of 
medical care for tuberculosis”, it can be observed that TB services are 
disproportionately distributed in favor of urban areas, potentially leaving a larger 
proportion of people from rural areas with poor access to TB care.  Geographic 
barriers related to rural living influence access to TB care and clinical outcomes 
[12]. Additionally, individual risk factors of rural residents such as low educational 
attainment and income can influence care-seeking behaviors, resulting in treatment 
delays and poor treatment adherence [13]. Poor access to health care could also 
lead patients to seek less credible alternative care [14]. Though urban residence is 
a recognized risk factor for TB, especially in rapidly urbanizing communities due 
to poor living conditions, [12] the gap in TB services coverage between the rural 
and urban areas may have worsened inequalities to treatment access which can 
affect the treatment outcome. In addition to providing specialist services such as 
diagnosis of extra-pulmonary and smear-negative TB, several tertiary-level 
facilities in the country (which are largely urban-based) also provide primary care 
services, such as diagnosis and treatment of pulmonary TB. This imbalance may 
also further worsen rural-urban inequalities in TB care. Establishing the effect of 
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rural residence in the context of the country provides important policy-relevant 
information. 
Previous Kazakhstani studies examine factors associated with tuberculosis 
cases; however, there is lack of studies that examined factors associated with 
treatment outcome [17-19]. Results of the Terlibekova study shows, that the 
highest prevalence in TB cases and multidrug cases are in East-Kazakhstan region: 
122 per 100,000 people, and 10.6 per 100,000 people respectively.  Due to high 
TB-burden in Kazakhstan, we anticipate that treatment success rate may drop due 
to expected increase in multi-drug resistant tuberculosis cases. The aim of this 
study to examine factors associated with adult pulmonary TB treatment outcomes 
in East-Kazakhstan region. And, we hope that this study will present the first 
comprehensive description of possible factors associated with treatment outcome 
in East-Kazakhstan region based on Kazakhstani information system “Electronic 
register of inpatient care”.  
Discrete goals of the study 
1. To examine factors associated with adult pulmonary Tb treatment 
outcome in East-Kazakhstan region; 
2. To provide useful information for further interventions, research, and 
policies to decrease rates of Tb in East-Kazakhstan region.  
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2. METHODS   
Study design and settings  
The study utilized a cross sectional study design. In research, data from 
information system “Electronic register of inpatient form” was used. In Kazakhstan, 
this register was developed in 2013 [16]. All medical organizations must enter all the 
cases using unified form of fata entry type [16]. E-medical records are stored on SQL 
server at National Center of Public Health development [16]. Data access was 
permitted by NJSC “Social Medical Health Insurance Fund.   
Subject selection information 
All secondary patient records aged 18 and older from the national enhanced 
TB surveillance system from 2015 to 2017 in East Kazakhstan region was eligible 
for inclusion. TB cases include all patients whose diagnosis was confirmed.  
Data entry and cleaning  
  Provided data was translated into English language in the Excel and then 
exported and analyzed in STATA 12.0 statistical package.  Data entry lasted one 
month.  Range and outlier check technique was used to clean the data.  
Data Analysis  
The study results were analyzed using STATA software [15]. Firstly, we 
conducted descriptive univariate analysis to illustrate relevant characteristics. 
Secondly, bivariate analysis was performed to identify statistically significant 
differences in factors and treatment outcome by performing Chi-square and Fisher’s 
  8 
exact tests for categorical variables, and Student t-test for continuous variables. Third, 
simple bivariate Poisson regression with robust equal variances to identify potentially 
significant (p<0.25) associations between factors and treatment outcome. Fourthly, 
the final multivariate Poisson regression with robust equal variances was used to 
calculate the adjusted prevalence risk ratios. This regression provides more reliable 
estimates than logistic regression in cross sectional studies with binary outcome 
analysis [20-21]. 
Variables  
Provided data from electronic register of inpatients had following 
information: 1) organization, where patient is getting treatment; 2) age of patient; 3) 
gender of patient; 4) hospital admission type (planned/emergency); 5) length of stay 
at hospital; 6) year of admission; 7) residence (urban or rural); 8) drug resistance (yes 
or no); 9) complication wit surgery (yes/no); 10) socio-economic status (unemployed, 
disabled, employed, pensioner, student) ; 11) treatment outcome. 
Treatment outcome variable had five categories: ‘treatment success’, ‘got 
better’, ‘no change’, ‘got worse’, and ‘death’. Treatment outcome categories such as 
‘treatment success’ and ‘got better’ has been classified as successful treatment 
outcome. And, other categories were classified as unsuccessful treatment outcome. 
Ethical considerations  
Institutional Review Board of the Nazarbayev University School of 
Medicine approved the research.  The research did not pose any significant risk to 
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the participants since secondary data did not include any identifiable information.  
The study focused only on information concerning TB treatment outcome.   
3. RESULTS  
Of the 3,198 patients, who were eligible to our study, 2,529 (79%) of all patients, 
669  (21%) of the pulmonary TB patients, had successful and unsuccessful 
treatment outcomes respectively. Mean age and frequency of complication with 
surgery between two treatment groups was not different, p-value was equal to 
0.6714 and 0.558 respectively (Table 1). The mean age for successful treatment 
outcome was equal to 42.64±14.67, and in unsuccessful treatment outcome 
42.90±14.47. Other frequencies of risk factors’ such as: sex; residence; socio-
economic status; year of admission; length of stay; drug resistance; medical 
organization, where patient has been treated; hospital admission was statistically 
different between two treatment groups outcomes, p-values were less than 0.1 
(Table 1).  
Table 1. Characteristics of individuals receiving standard initial tuberculosis 
treatment, comparing patients with successful treatment to patients with unsuccessful 
treatment.   
Variable Type 
Successful 
treatment outcome, 
n (%), n = 2529 
Unsuccessful 
treatment 
outcome, n (%), 
n = 669 
p-value 
Mean Age (years) 
  
42.64±14.67 42.90±14.47 0.6714* 
Sex Female 787 (31.12%) 158 (23.62%) <0.001 
Male 1742 (68.88%) 511 (76.38%) 
Residence Urban 1033 (59.15%) 421 (63.52%) 0.076 
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Rural  1496 (40.85%) 248 (37.07%) 
Socio-
economic 
status 
Unemployed 1536 (60.73%) 476 (71.15%) <0.001 
Disabled 119 (4.71%) 65 (9.72%) 
Employed 630 (24.91%) 81 (12.11%) 
Pensioners 202 (7.99%) 44 (6.57%) 
Students 43 (1.66%) 3 (0.44%) 
Year 2015 849 (33.57%) 248 (37.07%) <0.001 
2016 843 (33.33%) 267 (39.91%) 
2017 837 (33.10%) 154 (23.02%) 
Length of stay (in days) 
  
159.56±112.85 93.20±118.59 <0.001 
Drug 
resistance 
Yes 1298 (48.67%) 492 (73.54%) <0.001 
No 1231 (51.32%) 177 (26.46%) 
Medical 
organization 
Semey 1204 (47.61%) 367 (54.86%) 0.001 
  Ust’-Kamenogorsk 1325 (52.39%) 302 (45.14%) 
Hospital 
admission 
type 
Emergency 852 (33.69%) 305 (45.59%) <0.001 
Planned 1677(66.31%) 364 (54.41%) 
Complication 
with surgery 
Yes 7 (0.28%) 1 (0.15%) 0.558* 
No 2522 (99.72%)  668 2(99.85%)  
 
In a Poisson regression analysis with robust equal variances (Table 2.), patients 
who had drug resistance for TB were at higher risk of a unsuccessful treatment 
outcome (RR = 3.06±0.23, p-value≤0.01). Also, patients, who were emergency 
admitted to the hospital had a higher likelihood of treatment failure compared to those 
who were admitted to the hospital in planned manner (RR = 1.47±0.09, p-value≤0.01). 
Male patients have a higher risk of treatment failure in comparison to female patients 
(RR=1.17±0.09, p-value = 0.042). One additional stay at the hospital decrease the 
likelihood of treatment failure by 1% (RR = 0.99±0.001, p-value≤0.01). From the 
model, it could be observed that residence type does not influence on treatment failure, 
p-value= 0.219. Socio-economic status as being unemployed, disabled or pensioner 
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have approximately the same association with treatment outcome, while person’s who 
are employed or a student have less chances of treatment failure in comparison with 
people who are unemployed (RR=0.64±0.07, p-value<0.01; RR=0.35±0.19, p-
value=0.05, respectively). The most interesting observation is that patients that were 
admitted in 2017 decrease likelihood of treatment failure in comparison with other 
years (RR=0.57±0.05, p-value<0.01). Additionally, persons treated in Ust’-
Kamenogorsk TB center associated with decrease of likelihood of treatment failure in 
comparison to those who were treated in Semey TB center (RR=0.66±0.04, p-
value<0.01)  
Table 2. Risk factors for unsuccessful treatment outcome: Poisson regression 
with robust equal variances 
Variable Status Prevalence RR  p-value 
Sex Female 1  
Male 1.17±0.09 0.042 
Residence Rural  1  
Urban 0.92±0.06 0.219 
Socio-economic 
status 
Unemployed 1   
Disabled 1.23±0.11 0.24 
Employed 0.64±0.07 <0.01 
Pensioners 1.00±0.13 0.99 
Students 0.35±0.19 0.05 
Year 2015 1   
2016 0.99±0.07 0.98 
2017 0.57±0.05 <0.01 
Length of stay 1 day increment 0.99±0.001 <0.01 
Drug resistance No 1 <0.01 
Yes 3.06±0.23   
Medical 
organization 
Semey 1   
Ust’-
Kamenogorsk 
0.66±0.04 <0.01 
  12 
Hospital admission 
type 
Planned 1 <0.01 
Emergency 1.47±0.09   
 
4. DISCUSSION  
  
According to CDC, some people are affected by TB more than others. The occurrence 
of TB at greater levels among certain population groups is often referred as a health 
disparity [22]. Difference may occur by gender, race or ethnicity, income, comorbid 
medical conditions, residency, geographic location, etc. Our research results may help 
to achieve equity by addressing disparities.  
This research investigated factors associated with treatment outcome failure. The 
following factors has been examined: age, sex, residence, socio-economic status, year 
of admission, length of stay in the hospital, drug resistance, medical organization, 
hospital admission type. It has been found that following factors are associated with 
increased TB treatment outcome failure: being male by 17%; drug resistance by 206%; 
being emergency admitted to the hospital by 47%. Factors that are associated with 
decreased treatment outcome failure: being treated in Ust-Kamenogorsk TB center by 
34%; being employed (as compared to being unemployed) by 36%; being student (as 
compared to being unemployed) by 65%; one additional day of stay by 1%. However, 
it should be admitted that obtained factors’ association are generalizable for East-
Kazakhstan region only due to study design limitations.  
Age in our model does not have an influence on treatment outcome. However, WHO 
report represent that tuberculosis affects mostly people aged 25-34 among both sexes 
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[22]. It may imply that even though tuberculosis affects certain age group, age by itself 
does not have an association with treatment outcome.  
A disproportionate number of TB cases occur among high-risk populations, 
including people experiencing homelessness [23]. Our research results showed that 
treatment failure predominantly at higher risk among such socio-economic statuses as 
being unemployed, pensioner or disabled. From the secondary data that was provided, 
there was no information about whether patient is homeless or not. Therefore, they 
might be also in high-risk populations that may have higher risk of treatment outcome 
failure. 
Geographic barriers related to rural living influence access to TB care and 
clinical outcomes [12]. Poor access to health care could also lead patients to seek 
less credible alternative care [14]. Though urban residence is a recognized risk 
factor for TB, especially in rapidly urbanizing communities due to poor living 
conditions, [12] the gap in TB services coverage between the rural and urban areas 
may have worsened inequalities to treatment access which can affect the treatment 
outcome. Even though, our research shows that rural or urban residency in East-
Kazakhstan region does not have an association with treatment outcome. However, 
there is an association between medical organization, where patient has been 
treated and treatment outcome. This is an interesting factor that is associated with 
treatment outcome because, in fact, both organizations follow the same clinical 
protocols approved by Republican center of health development.  
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There is no information on how year of admission to the hospital influence 
on treatment outcome. Our results showed that admission at 2017 in comparison 
to 2015 decrease the likelihood of treatment failure. But definite explanation to 
this observation can not be made.  
5. Strength of the study 
Previous Kazakhstani studies investigated factors associate with TB cases that are 
alcohol use, diabetes, drug use, being incarcerated within past 2 years, being migrant, 
non-regular uptake of anti-tuberculosis medication, socio-economic status, being 
prison system staff member, being recent mother, being tuberculosis health care staff 
member, and HIV status [17-19]. However, there was no any studies in Kazakhstan 
that investigated factors associated with treatment outcome. It is a first comprehensive 
study in Kazakhstan to measure the factors associated with treatment result using 
multivariate analysis and first study in the regions of Kazakhstan with a big sample 
size.  
6. Limitations of the study  
Analytical cross-sectional study design is limited in its ability to draw valid 
conclusions about any association or possible causality because the presence of risk 
factors and outcomes are measured simultaneously. From this study design we cannot 
draw any causation patterns, it should always be confirmed by more rigorous studies. 
The collection of information about risk factors is provided by different organization 
staff members running the data entry issues. Moreover, it should be admitted that 
results of this study are generalizable only for East-Kazakhstan region. 
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7. RECOMMENDATIONS  
  
The study findings suggest the following steps and recommendations that 
could help to decrease unsuccessful pulmonary tuberculosis treatment outcome 
among adult population in East-Kazakhstan region:  
• To develop strategies to better treatment outcome for following high-risk 
groups: male population; people with socio-economic status as being 
unemployed, disabled, and being pensioner; people who has emergency 
admission; patients with drug resistance.  
• To conduct research to identify the reason for the differences between 
hospitals; 
• Further research is required for factors associated with multi-drug resistant 
TB treatment outcomes; 
• To develop strategies for listed high-risk groups applied to modern 
treatment regimens or clinical procedure.   
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